Accumulate Anupam Rasayan India; target of Rs 810: KR Choksey

Accumulate

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Anupam Rasayan’s revenue missed our estimate due to weak demand in Agrochemical segment. EBITDA missed our estimate due to higher operating expenses. We decrease our FY25E and FY26E EPS by 21.3% and 18.1%, respectively, due to weak quarterly performance and continued short-term challenges experienced in Agrochemical industry. Currently, the stock is trading at PE multiples of 58.6x/35.9x based on FY25E/FY26E EPS, respectively. We assign a PE multiple of INR 36x (previously: 30.0x) on FY26E EPS of INR 22.5 (previously: INR 27.5) to arrive at a target price of INR 810 (previously: INR 824) with revenue growth anticipate to resume in H2FY25E driven by higher contributions from the Polymer and Pharma segments, as well as the ramp-up of Letter of Intent (LOIs) and contracts.

We assign a PE multiple of INR 36.0x (previously: 30.0x) on FY26E EPS of INR 22.5 (previously: INR 27.5) to arrive at a target price of INR 810 (previously: INR 824) with revenue growth anticipate to resume in H2FY25E driven by higher contributions from the Polymer and Pharma segments, as well as the ramp-up of LOIs and contracts. Given a 5.2% upside, we maintain our rating of “ACCUMULATE” on the stock.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.